This includes loss of CXCL12+ adipogenic stromal cells and the emergence of a distinct population of inflammatory mesenchymal stromal cells (iMSCs), which arise in CHIP and become more prevalent in MDS. The gene discussed is CXCL12; the disease is myelodysplastic syndrome.